NHS Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)
Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a perio...
Buyer
NHS England
Value
£431,955,441
Published
15 Sept 2021
Closes
20 Oct 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)
£431,955,441
Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Isle of Man, London · United Kingdom, North East · United Kingdom, North West · United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
15 Sept 2021
Opportunity notice on Contracts Finder
Tender notice · Web page
Document No. 01 - Invitation to offer covering letter (A2486901)#3
Not provided
Document No. 01 - Invitation to offer covering letter (A2486901)#3
Link
Document No. 02 - Terms of offer
Not provided
Document No. 02 - Terms of offer
Link
Document No. 04 - Contract technical specification (A2383497)
Not provided
Document No. 04 - Contract technical specification (A2383497)
Link
Document No. 07a - Quality control technical sheet (A2383499)
Not provided
Document No. 07a - Quality control technical sheet (A2383499)
Link
Document No. 03 - Framework Agreement and Terms and Conditions
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions
Link
Document No. 05 - Selectt offer schedule instructions (A2383501)
Not provided
Document No. 05 - Selectt offer schedule instructions (A2383501)
Link
Document No. 05b(ii) - Tender Product Listing and Usage - CM_PHR_20_5600_02
Not provided
Document No. 05b(ii) - Tender Product Listing and Usage - CM_PHR_20_5600_02
Link
Document No. 05c - Volume discounts or Additional Products Offer Schedule
Not provided
Document No. 05c - Volume discounts or Additional Products Offer Schedule
Link
Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS (A2383503)
Not provided
Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS (A2383503)
Link
Document No. 05b(v) - Tender Product Listing and Usage - CM_PHR_20_5600_05
Not provided
Document No. 05b(v) - Tender Product Listing and Usage - CM_PHR_20_5600_05
Link
Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_20_5600_01
Not provided
Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_20_5600_01
Link
Contains public sector information licensed under the Open Government Licence v3.0.